Could probiotics cut Kids' colds? new trial tests antrrix in 120 children
NCT ID NCT07297966
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a daily probiotic supplement (Antrrix) can reduce the frequency and severity of respiratory infections in children under 6 who get sick often. Over 8 weeks, 120 kids will receive either the probiotic or a placebo. Researchers will track symptoms and quality of life, and also analyze gut bacteria to understand how the probiotic might work.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Antrrix probiotics (Lactobacillus rhamnosus CRL1505 and Bifidobacterium brevis M-16V)
- What this could lead to
- If it works, this could point toward a simple probiotic supplement to help young children have fewer and less severe respiratory infections.
- What could go wrong
- This is an early phase 2 trial with only 120 children, so results may not apply to all kids. Probiotics may not work for everyone, and the study is too small to confirm safety or effectiveness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT RESPIRATORY TRACT INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universiti Sains Malaysia
NOT_YET_RECRUITINGGeorge Town, Pulau Pinang, 11800, Malaysia
-
Xinyi City People's Hospital
RECRUITINGXingyi, Guangdong, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.